Can a herbal capsule beat cancer fatigue? new trial aims to find out
NCT ID NCT07669454
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This phase 3 trial tests whether Nuvastatic 300mg, a herbal supplement, can reduce cancer-related fatigue in adults with metastatic colorectal cancer who are receiving standard chemotherapy. About 250 participants will take either Nuvastatic or a placebo three times daily for about 120 days. The study measures fatigue levels and quality of life to see if the supplement offers meaningful relief.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Nuvastatic 300mg capsule (herbal supplement)
- What this could lead to
- If it works, this could provide a safe option to ease severe fatigue in people with advanced colon cancer undergoing chemotherapy.
- What could go wrong
- This is a mid-stage trial with 250 participants, so results may not apply to everyone. The supplement may not reduce fatigue more than a placebo, and side effects are still being studied.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Erode Cancer Care Centre
RECRUITINGErode, Tamil Nadu, 638012, India
-
International Oncology Cancer Tower 1
RECRUITINGKanpur, Uttar Pradesh, India
-
Jeevanjyoti Cancer Hospital
RECRUITINGJalgaon, Maharashtra, 425001, India
-
K R Hospital
RECRUITINGMysore, Karnataka, 570001, India
-
Omega Hospital Chinna Gadhili
RECRUITINGVisakhapatnam, Andhra Pradesh, 530040, India
-
Sangavi Multispeciality Hospital Pvt. Ltd,
RECRUITINGPune, Maharashtra, 411027, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Can delivering cancer drug directly to the liver shrink tumors?
- Blood biomarkers could replace invasive biopsies for colorectal cancer monitoring
- Can artificial intelligence think like a cancer tumor board?
- A new clue in the fight against colorectal cancer recurrence?
- One dose may not fit all: blood tests could tailor cancer drug dosing